Bio
Brittany Parke is the mother of two boys born with Cobalamin G. Sadly, Drew passed away in 2011 due to complications related to delayed diagnosis. Grayson was born in 2019 and treated since birth, giving him a chance to thrive. Brittany serves as vice president of the board and is the research coordinator. She oversees the Homocystinuria Data Collection Program through RARE-X. She has presented at 5 professional conferences around the globe, authored 7 scientific abstracts and has a recently published scientific article in Molecular Genetics and Metabolism Reports.
"Classical HCU & Remethylation Research Overview"
Tthe landscape of remethylation disorders—including MTHFR deficiency and cobalamin defects (CblC, D, E, F, G, J, K)—is rapidly evolving with new research priorities and therapeutic strategies. In this session, Brittany provides an essential update on the remethylation research map and the global efforts to accelerate treatments for these complex conditions. Drawing from her work and experience as a mother with a son with cblG, Brittany will discuss the shift toward clinical trial readiness, milestones achieved and future goals for the community.